This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Keefe, Bruyette & Woods Adjusts Price Target on Perella Weinberg Partners to $19 From $18, Maintains Outperform Rating MT
Merz Pharmaceuticals, LLC completed the acquisition of Substantially all of the assets of Acorda Therapeutics, Inc. for approximately $190 million. CI
Perella Weinberg Partners(NasdaqGS:PWP) dropped from Russell Microcap Growth Index CI
Perella Weinberg Partners(NasdaqGS:PWP) dropped from Russell 3000E Growth Index CI
Perella Weinberg Partners(NasdaqGS:PWP) dropped from Russell 3000E Index CI
Perella Weinberg Partners(NasdaqGS:PWP) dropped from Russell Microcap Index CI
Principal Financial Group, Inc. signed a definitive agreement to acquire ESOP Recordkeeping Business of Ascensus, LLC. CI
Tranche Update on Perella Weinberg Partners's Equity Buyback Plan announced on February 17, 2022. CI
Perella Weinberg Partners' Shares Fall After Reporting Swinging to a Q1 Adjusted Net Loss; Revenue Drops MT
Transcript : Perella Weinberg Partners, Q1 2024 Earnings Call, May 03, 2024
Earnings Flash (PWP) PERELLA WEINBERG PARTNERS GROUP LP Posts Q1 Revenue $102.1M, vs. Street Est of $133.7M MT
Earnings Flash (PWP) PERELLA WEINBERG PARTNERS GROUP LP Reports Q1 EPS $-0.10, vs. Street Est of $0.07 MT
Perella Weinberg Partners Declares a Quarterly Dividend of Class A Common Stock, Payable on June 10, 2024 CI
Perella Weinberg Partners Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
North American Morning Briefing : Apple, Amgen -2- DJ
Certain Class A Common Stock of Perella Weinberg Partners are subject to a Lock-Up Agreement Ending on 28-APR-2024. CI
Certain Restricted Stock Units of Perella Weinberg Partners are subject to a Lock-Up Agreement Ending on 28-APR-2024. CI
Banco Santander Hires DealMakers From Perella, William Blair, Moelis MT
Econocom: two new additions to the Board of Directors CF
Perella Weinberg Partners Appoints David Higley as Partner in the Advisory Business CI
Merz Pharmaceuticals, LLC entered into an asset purchase agreement to acquire Substantially all of the Companys assets of Acorda Therapeutics, Inc. for approximately $190 million. CI
US natgas prices soar 10% from 3-1/2-year low as Chesapeake cuts output RE
Munich's mountains and tech tempt big banks from Frankfurt RE
US natgas drillers cut spending, reduce activity amid price crash RE
US natgas price plunge to 3-year low could force producers to cut output RE
Chart Perella Weinberg Partners
More charts
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
17.36 USD
Average target price
18.88 USD
Spread / Average Target
+8.73%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. PWP Stock
  4. News Perella Weinberg Partners
  5. Earnings Flash (PWP) PERELLA WEINBERG PARTNERS GROUP LP Reports Q1 EPS $-0.10, vs. Street Est of $0.07